Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101 - Lin, T S; Donohue, K A; Byrd, J C (J Clin Oncol, 2010)